Retinoblastoma
| Primary Site | Histology |
|---|---|
| C690-C699 | 9510-9514 |
Notes
9510-9514: C690-C699 (all ages) **Note 1:** The following sources were used in the development of this schema * Toronto Childhood Cancer Stage Guidelines, Version 2, May 2022 https://cancerqld.blob.core.windows.net/content/docs/childhood-cancer-staging-for-population-registries.pdfData Items
| Name | Default Value | Used for Staging | NAACCR Item | Required By | Metadata |
|---|---|---|---|---|---|
| Year of Diagnosis | <BLANK> | No |
NAACCR #390
dateOfDiagnosis |
None | None |
| Primary Site | <BLANK> | Yes |
NAACCR #400
primarySite |
All | None |
| Histology | <BLANK> | Yes |
NAACCR #522
histologicTypeIcdO3 |
All | None |
| International Retinoblastoma Staging System | <BLANK> | No |
NAACCR #9612
intlRetinoblastomaStgSys |
SEER | SSDI |
Initial Context
Outputs
| Name | Default Value | Description | NAACCR Item | Metadata |
|---|---|---|---|---|
| Toronto ID | 5 | NAACCR IDs are not final |
NAACCR #9617
torontoId |
None |
| Toronto Version Number | 1 | NAACCR IDs are not final |
NAACCR #9620
torontoVersionNumber |
None |
| Derived Version | {{ctx_alg_version}} | None | None | |
| Derived Toronto T | 88 | NAACCR IDs are not final |
NAACCR #9607
derivedTorontoT |
None |
| Derived Toronto N | 88 | NAACCR IDs are not final |
NAACCR #9605
derivedTorontoN |
None |
| Derived Toronto M | 88 | NAACCR IDs are not final |
NAACCR #9604
derivedTorontoM |
None |
| Derived Toronto Stage Group | 88 | NAACCR IDs are not final |
NAACCR #9606
derivedTorontoStageGroup |
None |